A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Meredith Pelster, MD
SCRI Oncology Partners
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rocky Mountain Cancer Center - Primary
Denver, Colorado, United States
Recruiting - Illinois Cancer Specialists
Arlington Heights, Illinois, United States
Recruiting - Maryland Oncology Hematology
Columbia, Maryland, United States
Recruiting - Minnesota Oncology Hematology - Primary
Maple Grove, Minnesota, United States
Recruiting - Missouri Cancer Associates
Columbia, Missouri, United States
Recruiting - Oncology Associates of Oregon - Primary
Eugene, Oregon, United States
Recruiting - Northwest Cancer Specialists - Compass
Portland, Oregon, United States
Recruiting - Alliance Cancer Specialists
Wynnewood, Pennsylvania, United States
Recruiting - Scri Oncology Partners
Nashville, Tennessee, United States
Recruiting - Texas Oncology - Central/south Texas
Austin, Texas, United States
Recruiting - Texas Oncology - Gulf Coast
Beaumont, Texas, United States
Recruiting - Texas Oncology - Northeast Texas
Tyler, Texas, United States
Recruiting - Virginia Oncology Associates
Norfolk, Virginia, United States
Recruiting - Blue Ridge Cancer Care (oncology & Hematology Associates of Southwest Va)
Salem, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Sept 2025
- Primary completion
- 31 Jan 2027
- Completion
- 30 Jun 2027
- Last update posted
- 12 Jun 2026
- Registered enrollment
- 60
- Registry id
- NCT07011576
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.